SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
20-Jan-23 4:00 PM View: ![]() | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 19-Jan-23 | Grant | 51,300 | -- | -- | 6% 866.98K to 918.28K | |
20-Jan-23 4:00 PM View: ![]() | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 19-Jan-23 | Grant | 19,900 | -- | -- | 28% 71.57K to 91.47K | |
20-Jan-23 4:00 PM View: ![]() | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 19-Jan-23 | Grant | 20,700 | -- | -- | 112% 18.44K to 39.14K | |
20-Jan-23 4:00 PM View: ![]() | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 19-Jan-23 | Grant | 5,900 | -- | -- | 22% 27.24K to 33.14K | |
11-Jan-23 4:03 PM View: ![]() | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 10-Jan-23 | Payment of Exercise | 5,855 | $3.00 | $17,565.00 | (< 1%) 872.84K to 866.98K | |
11-Jan-23 4:05 PM View: ![]() | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 10-Jan-23 | Payment of Exercise | 5,225 | $3.00 | $15,675.00 | (7%) 76.8K to 71.57K | |
11-Jan-23 4:02 PM View: ![]() | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 10-Jan-23 | Payment of Exercise | 1,876 | $3.00 | $5,628.00 | (9%) 20.32K to 18.44K | |
04-Jan-23 4:25 PM View: ![]() | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 03-Jan-23 | Payment of Exercise | 6,604 | $2.80 | $18,491.20 | (< 1%) 879.44K to 872.84K | |
04-Jan-23 4:26 PM View: ![]() | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 03-Jan-23 | Payment of Exercise | 2,159 | $2.80 | $6,045.20 | (3%) 78.96K to 76.8K | |
04-Jan-23 4:24 PM View: ![]() | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 03-Jan-23 | Payment of Exercise | 361 | $2.80 | $1,010.80 | (1%) 27.6K to 27.24K | |
30-Dec-22 6:00 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 30-Dec-22 | Private Sale | 15,473 | $2.71 | $41,948.90 | < 1% 2.68M to 2.69M | |
15-Sep-22 4:05 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 15-Sep-22 | Purchase | 7,300 | $3.80 | $27,740.00 | < 1% 2.7M to 2.71M | |
15-Sep-22 4:05 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 14-Sep-22 | Private Purchase | 16,600 | $3.98 | $66,068.00 | < 1% 2.68M to 2.7M | |
15-Aug-22 5:49 PM View: ![]() | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 11-Aug-22 | Private Purchase | 9,065 | $3.84 | $34,809.60 | 1% 870.38K to 879.44K | |
19-Jul-22 4:06 PM View: ![]() | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 16-Jul-22 | Grant | 25,000 | -- | -- | 962% 2.6K to 27.6K | |
19-Jul-22 4:31 PM View: ![]() | Davis Blaine Chief Financial Officer | Protara Therapeutics, Inc. (TARA) | 15-Jul-22 | Payment of Exercise | 5,081 | $3.13 | $15,903.50 | (20%) 25.74K to 20.66K | |
05-Jul-22 5:00 PM View: ![]() | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 01-Jul-22 | Payment of Exercise | 682 | $3.22 | $2,196.04 | (3%) 21.0K to 20.32K | |
05-Jul-22 5:00 PM View: ![]() | Beshar Luke M Director | Protara Therapeutics, Inc. (TARA) | 30-Jun-22 | Private Purchase | 10,000 | $3.10 | $31,000.00 | 5% 188.0K to 198.0K | |
08-Apr-22 6:45 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 08-Apr-22 | Purchase | 7,791 | $4.80 | $37,364.10 | < 1% 2.55M to 2.56M | |
08-Apr-22 6:45 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 07-Apr-22 | Private Purchase | 2,345 | $4.74 | $11,122.80 | < 1% 2.67M to 2.68M | |
16-Mar-22 4:37 PM View: ![]() | Beshar Luke M Director | Protara Therapeutics, Inc. (TARA) | 14-Mar-22 | Private Purchase | 10,000 | $4.25 | $42,500.00 | 6% 178.0K to 188.0K | |
14-Mar-22 4:37 PM View: ![]() | Beshar Luke M Director | Protara Therapeutics, Inc. (TARA) | 10-Mar-22 | Private Purchase | 10,000 | $4.46 | $44,555.00 | 6% 168.0K to 178.0K | |
31-Jan-22 4:05 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 28-Jan-22 | Private Purchase | 24,031 | $4.96 | $119,271.00 | < 1% 2.65M to 2.67M | |
12-Jan-22 5:20 PM View: ![]() | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 10-Jan-22 | Payment of Exercise | 4,603 | $6.27 | $28,860.80 | (6%) 83.56K to 78.96K | 0% |
12-Jan-22 5:18 PM View: ![]() | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 10-Jan-22 | Payment of Exercise | 5,080 | $6.27 | $31,851.60 | (< 1%) 877.5K to 872.42K | 0% |
12-Jan-22 5:16 PM View: ![]() | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 10-Jan-22 | Grant | 13,500 | -- | -- | 100% 0 to 13.5K | |
05-Jan-22 4:35 PM View: ![]() | Davis Blaine Chief Financial Officer | Protara Therapeutics, Inc. (TARA) | 03-Jan-22 | Grant | 14,100 | -- | -- | 952% 1.48K to 15.58K | |
05-Jan-22 4:36 PM View: ![]() | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 03-Jan-22 | Grant | 42,300 | -- | -- | 5% 835.21K to 877.5K | |
05-Jan-22 4:37 PM View: ![]() | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 03-Jan-22 | Grant | 14,100 | -- | -- | 20% 69.46K to 83.56K | |
29-Dec-21 7:36 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 29-Dec-21 | Market Purchase | 4,500 | $6.98 | $31,407.80 | < 1% 2.65M to 2.65M | (9%) |
29-Dec-21 7:36 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 28-Dec-21 | Market Purchase | 7,091 | $6.36 | $45,090.20 | < 1% 2.64M to 2.65M | < 1% |
27-Dec-21 6:52 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 27-Dec-21 | Market Purchase | 36,700 | $6.53 | $239,713.00 | 1% 2.6M to 2.64M | |
27-Dec-21 6:52 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 23-Dec-21 | Market Purchase | 1,300 | $6.60 | $8,580.00 | < 1% 2.6M to 2.6M | 5% |
22-Dec-21 4:05 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 20-Dec-21 | Market Purchase | 703 | $6.49 | $4,562.47 | < 1% 2.5M to 2.5M | 4% |
20-Dec-21 4:00 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 17-Dec-21 | Market Purchase | 2,790 | $6.60 | $18,414.00 | < 1% 2.6M to 2.6M | 1% |
20-Dec-21 4:00 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 16-Dec-21 | Market Purchase | 7,563 | $6.41 | $48,484.90 | < 1% 2.59M to 2.6M | 4% |
19-Nov-21 4:10 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 18-Nov-21 | Market Purchase | 15,206 | $6.98 | $106,130.00 | < 1% 2.57M to 2.59M | < 1% |
19-Nov-21 4:10 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 17-Nov-21 | Market Purchase | 9,118 | $6.98 | $63,643.60 | < 1% 2.57M to 2.57M | < 1% |
08-Nov-21 2:30 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 04-Nov-21 | Private Purchase | 6,557 | $6.50 | $42,620.50 | < 1% 2.56M to 2.57M | |
14-Jun-21 5:52 PM View: ![]() | Olivo Martin Sebastian Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 10-Jun-21 | Market Purchase | 9,893 | $10.10 | $99,968.10 | 222% 4.45K to 14.34K | (1%) |
13-Jan-21 5:19 PM View: ![]() | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 11-Jan-21 | Payment of Exercise | 4,653 | $21.16 | $98,457.50 | (6%) 74.11K to 69.46K | 56% |
13-Jan-21 5:16 PM View: ![]() | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 11-Jan-21 | Payment of Exercise | 5,069 | $21.16 | $107,260.00 | (< 1%) 840.27K to 835.21K | 56% |
02-Oct-20 6:05 AM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 30-Sep-20 | Market Purchase | 50,000 | $16.00 | $800,000.00 | 2% 2.51M to 2.56M | (46%) |
25-Sep-20 5:15 PM View: ![]() | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 24-Sep-20 | Market Purchase | 300,000 | $16.87 | $5,061,000.00 | 14% 2.21M to 2.51M | (49%) |
23-Sep-20 9:20 AM View: ![]() | Davis Blaine Chief Financial Officer | Protara Therapeutics, Inc. (TARA) | 22-Sep-20 | Market Purchase | 1,481 | $16.91 | $25,037.80 | 100% 0 to 1.48K | (49%) |
15-Sep-20 6:04 PM View: ![]() | Marshall Randall | Protara Therapeutics, Inc. (TARA) | 14-Sep-20 | Market Sale | 2,554 | $19.40 | $49,540.80 | (< 1%) 588.15K to 585.6K | 56% |
14-Sep-20 4:37 PM View: ![]() | Marshall Randall 10% Owner | Protara Therapeutics, Inc. (TARA) | 10-Sep-20 | Market Sale | 239 | $18.00 | $4,302.00 | (< 1%) 588.39K to 588.15K | 52% |
10-Sep-20 3:58 PM View: ![]() | Marshall Randall 10% Owner | Protara Therapeutics, Inc. (TARA) | 09-Sep-20 | Market Sale | 10,222 | $18.66 | $190,766.00 | (2%) 598.62K to 588.39K | 54% |
10-Sep-20 3:58 PM View: ![]() | Marshall Randall 10% Owner | Protara Therapeutics, Inc. (TARA) | 08-Sep-20 | Market Sale | 3,108 | $18.94 | $58,865.50 | (< 1%) 601.72K to 598.62K | 55% |
04-Sep-20 4:39 PM View: ![]() | Marshall Randall 10% Owner | Protara Therapeutics, Inc. (TARA) | 03-Sep-20 | Market Sale | 52 | $20.19 | $1,049.88 | (< 1%) 601.77K to 601.72K | 57% |